VALIDATION IMAGES
Paraformaldehyde-fixed and paraffin-embedded Human tonsil tissue incubated with NFkB p105/p50 (12G3) Monoclonal Antibody (bsm-52309R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human spleen tissue incubated with NFkB p105/p50 (12G3) Monoclonal Antibody (bsm-52309R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human breast carcinoma tissue incubated with NFkB p105/p50 (12G3) Monoclonal Antibody (bsm-52309R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse bladder tissue incubated with NFkB p105/p50 (12G3) Monoclonal Antibody (bsm-52309R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Lane 1: Human Raji cell lysates; Lane 2: Human MCF-7 cell lysates; Lane 3: Human Jurkat cell lysates; Lane 4: Human A431 cell lysates; Lane 5: Human HeLa cell lysates probed with NFKB1 Monoclonal Antibody, Unconjugated (bsm-52309R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.